€¦ · Control in year 1 Evolocumab in year 2+ N: 325 216 20 subjects did not receive IP 681...
74
€¦ · Control in year 1 Evolocumab in year 2+ N: 325 216 20 subjects did not receive IP 681 Study 651 30 632 599 33 Discontinued IP 5 consent withdrawn 8 adverse event 1 pregnancy